Clindamycin Phosphate NDC 45802-900

NDC codes

FDA NDC Directory

Product NDC (as listed)45802-900Labeler and product segments. Claims need a package NDC.

Product NDC at billing width45802-0900Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
45802-900-94	45802090094	1 TUBE in 1 CARTON (45802-900-94) / 30 g in 1 TUBEMarketed from Jan 20, 2021
45802-900-96	45802090096	1 TUBE in 1 CARTON (45802-900-96) / 60 g in 1 TUBEMarketed from Jan 20, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin Phosphate
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 10 mg/g
Dosage form: Gel
Route: Topical
Labeler: Padagis Israel Pharmaceuticals Ltd
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212104
Marketing start: Jan 20, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 45802-900_435a43c6-e6a0-447c-bd8e-a072fd096120SPL ID 435a43c6-e6a0-447c-bd8e-a072fd096120SPL set ID 6f72b852-e741-48e5-b8e1-f8a1afcfb4d4RxCUI 2676585UNII EH6D7113I8
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N445802090094 followed by a unit qualifier and the quantity

Package 45802-0900-94. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 1, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin Phosphate Gel is indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see CONTRAINDICATIONS , WARNINGS and ADVERSE REACTIONS ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212104

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212104
Product	Strength	Form · route	Labeler	Product NDC
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Bryant Ranch Prepack	72162-1436
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Bryant Ranch Prepack	63629-8631
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Bryant Ranch Prepack	63629-8630
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Bryant Ranch Prepack	63629-9309